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Neonatal central cyanosis is always a sign ofserious pathological processes and may involve diverse organs and impose a signiﬁcant
diagnostic and therapeutic challenge. Here, we report an unusual presentation of Ebstein’s anomaly, a rare congenital heart
malformation, as the cause of central cyanosis in a one-week-old full-term infant. Initiation of PEG1 therapy in neonates with
Ebstein’s anomaly always needs a very careful consideration because of a high risk for the development of a “circular shunt”
leading to severe deterioration of multiple organs perfusion.
1.Introduction
Cyanosis is a blue discoloration of the skin and mucus
membranes caused by an increased concentration of reduced
hemoglobin (>1.9–3.1mmol/L) in the blood. Peripheral and
central forms of cyanosis are well recognized. Peripheral or
acrocyanosis in newborns is regarded as a benign transient
discoloration of the hands and feet. Central cyanosis is a
serious pathological sign and involves discoloration of lips
and tongue. The list of the pathophysiological causes and
themostcommondisorderssummarizedinFigure 1.Clearly,
it can be a formidable task to reach the right diagnosis in
a neonate with central cyanosis. The case presented below
illustrates diagnostic and management challenges.
2.CaseReport
A female neonate was delivered at term following unremark-
ableprenatalcoursewithnormalfetalultrasound.Theinfant
was delivered via elective cesarian section. The Apgar scores
were 9 and 9 at the ﬁrst and ﬁfth minute, respectively. The
birth weight was 2525g with a normal body length and head
circumference.
On the 8th day of life, the infant exhibited cen-
tral cyanosis during crying. On physical examination, the
nondysmorphic infant was found to be cyanotic, warm, and
well perfused. Vital signs at that time were as follows: body
temperature of 36.8◦C, heart rate 193beats/min, respiratory
rate 45breaths/min, pre and postductal oxygen saturations
77% and 81%, respectively, and blood pressure 93/45mmHg
without gradient between upper and lower extremities.
Chest examination showed clear breath sounds bilaterally
without retractions. Cardiovascular examination revealed
quiet precordium, a regular rhythm with normal S1 and S2,
no murmurs, and palpable femoral pulses. Abdomen was
softwithouthepatosplenomegalyormasses.Themuscletone
was appropriate for age. Arterial blood gas sampled from
the right wrist on room air demonstrated a pH of 7.39,
pO2 of 42mmHg, pCO2 32mmHg, and arterial lactate of
8.7mmol/L. The infant failed the hyperoxia test on CPAP
FiO2 1.0 (pO2 66mmHg). Sepsis evaluation (complete blood
count, C-reactive protein, and blood culture) was performed
and antibiotic therapy was commenced. Chest X-ray illus-
trated a mildly enlarged boot-shaped cardiac silhouette with
absent pulmonary artery shadows, oligemic lung ﬁelds, and
no focal pathology (Figure 2). Electrocardiogram (EKG)
showednormalsinusrhythm,QRSaxisof+20◦,andnoright
ventricular forces in V1-V2. Transthoracic ECHO revealed
an unobstructed antegrade ﬂow into the hypoplastic right
ventricle and outﬂow without evident restriction or insuﬃ-
ciency (Figure 3(a)); a signiﬁcantly echogenic tricuspid valve
with inferior displacement of anterior and septal leaﬂets into
the ventricle and absent tricuspid valve regurgitation (Figure
3(a)); right atrium moderately dilated with right-to-left2 ISRN Pediatrics
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shunting through the foramen ovale (Figure 3(b)); no ﬂow
through the ductus arteriosus. Consequently, a diagnosis of
Ebstein’s anomaly was made.
Prostaglandin E1 (PGE1) therapy was not initiated due
to presence of forward ﬂow through the pulmonary valve
and the oxygen saturation above 80% on CPAP FiO2
0.45. Arterial lactate level normalized within 24 hours
from the admission, and respiratory support was gradually
discontinued. The infant remained on room air with oxygen
saturations in the 80s without desaturations. Following
period of stabilization, oral feeding was resumed and the
infant was able to nipple ad libitum. The blood culture
remained negative and the antibiotics were discontinued
after 48 hours.
No surgical intervention was needed, and the infant
was discharged home on the 4th day from the admission.
Two-month followup revealed that the patient’s appropriate
growth and development was suitable for her age, and her
oxygen saturations were in the high 80s on room air.
3. Discussion
Thepresentedcaserepresentsacommonchallengeinneona-
tology. The presence of central cyanosis in the newborn
without respiratory distress, with boot-shaped cardiomegaly
and failed hyperoxia test favored a diagnosis of congenital
heart disease. Absence of normal neonatal right-sided forces
on EKG would have likely entertained a possible diagnosis of
pulmonary atresia with intact ventricular septum, tricuspid
valve atresia, or Ebstein’s anomaly. However, these anomalies
areassociatedwithpresenceofheartmurmuronthephysical
examination. In our patient it would be impossible to cor-
rectly diagnose mild form of Ebstein’s anomaly without the
ECHO evaluation. The patient became cyanotic at the time
of ductus arteriosus closure, which limited pulmonary blood
ﬂow[1].Ebstein’s anomalyis arare cyanotic congenitalheart
disease (recently reviewed elsewhere [2–4]) with wide range
of severity in time of presentation.ISRN Pediatrics 3
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Management of neonates with cyanotic congenital heart
disease frequently begins with PGE1 infusion to keep the
ductus arteriosus patent. This is especially true in smaller
neonatal intensive care units without in-house cardiologists.
It should be noted that empirical therapy with PGE1 might
pose a serious risk for the development of a “circular shunt”
in patients with Ebstein’s anomaly [5]o rt e t r a l o g yo fF a l l o t
with absent pulmonary valve. Blood ﬂow through the ductus
arteriosus in these patients maintains a high pulmonary
artery pressure that can exceed right ventricular pressure and
cause signiﬁcant pulmonary valve insuﬃciency (Figure 4).
This increases tricuspid valve regurgitation, which further
lowers right ventricular pressure and increases right atrial
pressure. High right atrial pressure promotes a right-to-left
shunt via the foramen ovale to the left atrium and ﬁnally
to the aorta toward the open ductus arteriosus completing
the hemodynamically ineﬃcient “circular shunt.” “Circular
shunts” lead to severe reduction in systemic blood ﬂow
and oxygen delivery and manifest with refractory metabolic
acidosis and multiple-organ dysfunction syndrome. There-
fore, prior to initiation of PGE1 therapy in neonates with
Ebstein’s anomaly, it is extremely important to verify the
absence of pulmonary valve insuﬃciency. However, PGE1
should not be withheld if ECHO is unavailable. If PGE1
therapy is used in these patients, it is important to provide
close monitoring of adequate systemic circulation (blood
pressure, arterial blood gases with lactate, urine output).
Prompt discontinuation of PGE1 infusion is necessary if the
infant demonstrates signs of poor systemic oxygen delivery
duetotheriskof“circularshunt”[5].Iftheductusarteriosus
remains patent, urgent surgical ligation of the ductus will
abolish the “circular shunt”. Antegrade pulmonary blood
ﬂow may be enhanced by pulmonary vasodilators (oxygen,
inhaled nitric oxide).
In conclusion, central cyanosis in the newborn is sign
of serious underlying pathological process requiring urgent
detailed evaluation by neonatologist, and appropriate ther-
apy may require a highly specialized individual approach.4 ISRN Pediatrics
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